Published in
Wiley, Alimentary Pharmacology and Therapeutics, 9(44), p. 946-956, 2016
DOI: 10.1111/apt.13790
Links
Tools
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study
Journal article published in 2016 by
R. Flisiak,
E. Janczewska 
,
M. Wawrzynowicz-Syczewska,
J. Jaroszewicz,
D. Zarębska-Michaluk ,
K. Nazzal,
B. Bolewska,
J. Bialkowska,
H. Berak,
K. Fleischer-Stępniewska,
K. Tomasiewicz,
K. Karwowska,
K. Rostkowska,
A. Piekarska,
O. Tronina
and other authors.
,
M. Wawrzynowicz-Syczewska,
J. Jaroszewicz,
D. Zarębska-Michaluk ,
K. Nazzal,
B. Bolewska,
J. Bialkowska,
H. Berak,
K. Fleischer-Stępniewska,
K. Tomasiewicz,
K. Karwowska,
K. Rostkowska,
A. Piekarska,
O. Tronina
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 